The biggest reductions were seen in men and in people who reported joint or muscle pain
Campbell JE, Drucker DJ
Beyond T2D and obesity, semaglutide was also applied for other indications such as cardiovascular disease, fatty liver, chronic kidney disease, all of which have progressed to Phase 3, expanding the influence of GLP-1RAs into more medical fields
8 Notably, in patients with obesity and HFpEF, these dedicated HFpEF trials showed a significant improvement in patient-reported outcomes measured by the KCCQ-CSS
There are no known direct interactions between Wegovy and commonly used thyroid medicines such as levothyroxine
La gestin de lmites, recordatorios y herramientas de juego responsable est accesible desde el perfil, con reportes que puedes consultar en cualquier momento